Stephanie Schörner

Stephanie Schörner

Auto-generated profile, based on publicly available information

Stephanie Schörner

Center for Protein Diagnostics (PRODI), Deptartment of Biophysics, Ruhr University Bochum, Bochum, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2023 in European Journal of Cancer
Verified
Journal Article
Open access
KGKlaus Gerwert
Klaus Gerwert
SSStephanie Schörner
Stephanie Schörner
FGFrederik Großerueschkamp
Frederik Großerueschkamp
AKAnna–Lena Kraeft
Anna–Lena Kraeft
DSDavid Schuhmacher
David Schuhmacher
ATAndrea Tannapfel
Andrea Tannapfel
Microsatellite instability (MSI) due to mismatch repair (MMR) defects accounts for 15-20% of colon cancers (CC). MSI testing is currently standard of care in CC with immunohistochemistry of the four MMR proteins representing the gold standard. Instead, label-free quantum cascade laser (QCL) based infrared (IR) imaging combined with artificial intelligence (AI) may classify MSI/microsatellite stability (MSS) in unstained tissue sections user-independently and tissue preserving. Paraffin-embedded unstained tissue sections of early CC from patients participating in the multicentre AIO ColoPredict Plus (CPP) 2.0 registry were analysed after dividing into three groups (training, test, and validation). IR images of tissue sections using QCL-IR microscopes were classified by AI (convolutional neural networks [CNN]) using a two-step approach. The first CNN (modified U-Net) detected areas of cancer while the second CNN (VGG-Net) classified MSI/MSS. End-points were area under receiver operating characteristic (AUROC) and area under precision recall curve (AUPRC). The cancer detection in the first step was based on 629 patients (train n = 273, test n = 138, and validation n = 218). Resulting classification AUROC was 1.0 for the validation dataset. The second step classifying MSI/MSS was performed on 547 patients (train n = 331, test n = 69, and validation n = 147) reaching AUROC and AUPRC of 0.9 and 0.74, respectively, for the validation cohort. Our novel label-free digital pathology approach accurately and rapidly classifies MSI vs. MSS. The tissue sections analysed were not processed leaving the sample unmodified for subsequent analyses. Our approach demonstrates an AI-based decision support tool potentially driving improved patient stratification and precision oncology in the future.

24 August 2022 in Medical Image Analysis
Verified
Journal Article
Open access
DSDavid Schuhmacher
David Schuhmacher
SSStephanie Schörner
Stephanie Schörner
CKClaus Küpper
Claus Küpper
FGFrederik Großerueschkamp
Frederik Großerueschkamp
CSCarlo Sternemann
Carlo Sternemann
AMAxel Mosig
Axel Mosig
In recent years, deep learning has been the key driver of breakthrough developments in computational pathology and other image based approaches that support medical diagnosis and treatment. The underlying neural networks as inherent black boxes lack transparency and are often accompanied by approaches to explain their output. However, formally defining explainability has been a notorious unsolved riddle. Here, we introduce a hypothesis-based framework for falsifiable explanations of machine learning models. A falsifiable explanation is a hypothesis that connects an intermediate space induced by the model with the sample from which the data originate. We instantiate this framework in a computational pathology setting using hyperspectral infrared microscopy. The intermediate space is an activation map, which is trained with an inductive bias to localize tumor. An explanation is constituted by hypothesizing that activation corresponds to tumor and associated structures, which we validate by histological staining as an independent secondary experiment.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
KGKlaus Gerwert
Klaus Gerwert
SSStephanie Schörner
Stephanie Schörner
FGFrederik Großerüschkamp
Frederik Großerüschkamp
AKAnna-Lena Kraeft
Anna-Lena Kraeft
DSDavid Schuhmacher
David Schuhmacher
ATAndrea Tannapfel
Andrea Tannapfel
Purpose: Microsatellite instability (MSI) due to mismatch repair (MMR) defects accounts for 15-20% of colon cancers (CC). MSI testing is currently standard of care in CC with immunohistochemistry of the four MMR-proteins representing the gold standard. Instead, label-free quantum cascade laser (QCL) based infrared (IR) imaging combined with artificial intelligence (AI) may classify MSI/microsatellite stability (MSS) in unstained tissue sections user-independently and tissue preserving. Methods: Paraffin-embedded unstained tissue sections of early CC from patients participating in the multicentre AIO ColoPredict Plus (CPP) 2.0 registry were analysed after dividing into three groups (training, test, validation). IR images of tissue sections using QCL-IR microscopes were classified by AI (convolutional neural networks, CNN) using a two-step approach. The first CNN (modified U-Net) detected areas of cancer while the second CNN (VGG-Net) classified MSI/MSS. Endpoints were area under receiver operating characteristic (AUROC) and area under precision recall characteristic (AUPRC). Results: The cancer detection in the first step was based on 629 patients (train n=273, test n=138, validation n=218). Resulting classification AUROC was 1.0 for the validation dataset. The second step classifying MSI/MSS was performed on 547 patients (train n=331, test n=69, validation n=147) reaching AUROC and AUPRC of 0.9 and 0.74, respectively, for the validation cohort. Conclusion: Our novel label-free digital pathology approach accurately and rapidly classifies MSI vs. MSS. The tissue sections analysed were not processed leaving the sample unmodified for subsequent analyses. Our approach demonstrates an AI-based decision support tool potentially driving improved patient stratification and precision oncology in the future.